Altered receptor expression and decreased sensitivity of T-cells to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV infection

Immunol Lett. 1998 Mar;61(1):53-61. doi: 10.1016/s0165-2478(97)00162-4.

Abstract

A dysregulated production of regulatory cytokines has been proposed as a determinant in the progression of HIV infection. The sensitivity of T-cells to these cytokines has, however, not fully been investigated. Therefore, the responses of PBMC and T-cell subsets to the stimulatory cytokines IL-2, IL-7 and IL-12 in HIV-infected patients and HIV-negative controls were compared by examining their effect on the production of secondary cytokines (IFNgamma, IL-4 and IL-10), by simultaneous determination of T-cell activation and apoptosis and by measuring cytokine receptor expression. Production of IFNgamma was decreased in PBMC from the patients after stimulation with several combinations of stimulatory cytokines. IL-10 was only induced upon stimulation with IL-2 and IL-12 and tended to be produced more in patients. Expression of the different cytokine receptor chains showed complex alterations in HIV+ patients as compared to controls. The most pronounced changes were decreased expression of both IL-2Ralpha and IL-7Ralpha chain on CD8+ T-cells and an increase of IL-12Rbeta on both T-cell subsets from the patients. Evaluation of CD25 upregulation and blast formation revealed a deficient response to all three stimulatory cytokines in CD8+ but not in CD4+ T-cells from patients as compared to controls. Both CD4+ and CD8+ T-cells from the patients were less sensitive to the anti-apoptotic effect of IL-7 whereas only CD8+ T-cells were less sensitive to the anti-apoptotic effect of IL-2. The present data show that CD8+ T-cells, and to a lesser extent CD4+ T-cells, become less sensitive to IL-2, IL-7 and IL-12 during HIV infection. The decreased capacity of T-cells to respond to these cytokines could contribute to the HIV-related immune dysfunction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antigens, CD / biosynthesis
  • Apoptosis / drug effects
  • CD4-Positive T-Lymphocytes / metabolism
  • CD8-Positive T-Lymphocytes / cytology
  • CD8-Positive T-Lymphocytes / drug effects
  • CD8-Positive T-Lymphocytes / metabolism
  • HIV Infections / immunology*
  • Humans
  • Interferon-gamma / biosynthesis
  • Interferon-gamma / blood
  • Interleukin-10 / biosynthesis
  • Interleukin-10 / blood
  • Interleukin-12 / pharmacology*
  • Interleukin-2 / pharmacology*
  • Interleukin-4 / biosynthesis
  • Interleukin-4 / blood
  • Interleukin-7 / pharmacology*
  • Leukocytes, Mononuclear / cytology
  • Leukocytes, Mononuclear / drug effects
  • Leukocytes, Mononuclear / metabolism
  • Lymphocyte Activation / drug effects
  • Middle Aged
  • Receptors, Antigen, T-Cell / biosynthesis*
  • Receptors, Cytokine / biosynthesis
  • Receptors, Interleukin / biosynthesis
  • Receptors, Interleukin-12
  • Receptors, Interleukin-2 / biosynthesis
  • Receptors, Interleukin-7
  • T-Lymphocytes / cytology
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / metabolism*
  • Up-Regulation / drug effects

Substances

  • Antigens, CD
  • Interleukin-2
  • Interleukin-7
  • Receptors, Antigen, T-Cell
  • Receptors, Cytokine
  • Receptors, Interleukin
  • Receptors, Interleukin-12
  • Receptors, Interleukin-2
  • Receptors, Interleukin-7
  • Interleukin-10
  • Interleukin-12
  • Interleukin-4
  • Interferon-gamma